Finance

Beta
Lists
AAPG:NASDAQ
Ascentage Pharma Group Internatinl - ADR
၁၈.၆၉ US$
-၈.၃၈%
(-၁.၇၁) 1D
ဇူ ၁၇, GMT-၄ ၁၁:၁၃:၃၂  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AAPG...
Open
၁၉.၂၅ US$
High
၁၉.၂၅ US$
Low
၁၈.၆၀ US$
Mkt. cap
ဋေ ၁.၃၄ ထ
Avg. vol.
၁.၅၇ သောင်း
Volume
၁.၁၃ သောင်း
52-wk high
၄၈.၄၅ US$
52-wk low
၁၆.၃၆ US$
Shares outstanding
၉.၃၄ ကုဋေ
No. of employees
၇၆၇
Open
၁၉.၂၅ US$
High
၁၉.၂၅ US$
Low
၁၈.၆၀ US$
Mkt. cap
ဋေ ၁.၃၄ ထ
Avg. vol.
၁.၅၇ သောင်း
Volume
၁.၁၃ သောင်း
52-wk high
၄၈.၄၅ US$
52-wk low
၁၆.၃၆ US$
Shares outstanding
၉.၃၄ ကုဋေ
No. of employees
၇၆၇
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၈ မိနစ်
Can Millicom International Cellular (NasdaqGS:TIGO) Stay Cheap After A Huge Run?
ChartMill
ChartMill
·
ပြီးခဲ့သည့် ၃၃ မိနစ်
These S&P500 stocks have an unusual volume in today's session
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၂၉ မိနစ်
3Knights Dynamics Group files for Nasdaq IPO at $4-$5 per share
About Ascentage Pharma Group Internatinl - ADR
CEODajun Yang
Employees၇၆၇
Founded၂၀၀၉
Headquarters-
Sector-
Analyst ratings
Based on 6 analysts giving stock ratings to AAPG in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for AAPG in the last 3 months.
Highest
Current ၁၈.၆၉ US$
၄၈.၀၀ US$ (+၁၅၆.၈၂%)
Average
၄၁.၃၉ US$ (+၁၂၁.၄၆%)
Lowest
၂၂.၃၄ US$ (+၁၉.၅၃%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeff Jones
Oppenheimer
Buy
Initiated
၄၅.၀၀ US$
+၁၄၀.၈%
06/15/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
၄၅.၀၀ US$
+၁၄၀.၈%
06/10/2026
Biren Amin
Piper Sandler
Buy
Maintained
၄၈.၀၀ US$
+၁၅၆.၈%
06/01/2026
Jeet Mukherjee
BTIG
Buy
Maintained
၄၈.၀၀ US$
+၁၅၆.၈%
05/13/2026
Gregory Renza
Truist Financial
Buy
Maintained
၂၂.၃၄ US$
+၁၉.၅%
04/24/2026
James Shin
Deutsche Bank
Buy
Initiated
၄၀.၀၀ US$
+၁၁၄%
04/24/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
၄၆.၀၀ US$
+၁၄၆.၁%
04/15/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
၄၅.၀၀ US$
+၁၄၀.၈%
03/27/2026
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
၂၀၂၅ မတ်
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
Revenue
၁၁.၆၈ ကုဋေ
၁၁.၆၈ ကုဋေ
၁၇.၀၂ ကုဋေ
၁၇.၀၂ ကုဋေ
Cost of goods sold
၁.၀၈ ကုဋေ
၁.၀၈ ကုဋေ
၁.၃၆ ကုဋေ
၁.၃၆ ကုဋေ
Cost of revenue
၁.၀၈ ကုဋေ
၁.၀၈ ကုဋေ
၁.၃၆ ကုဋေ
၁.၃၆ ကုဋေ
Research and development expenses
၂၆.၄၃ ကုဋေ
၂၆.၄၃ ကုဋေ
၃၀.၄၄ ကုဋေ
၃၀.၄၄ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၁.၈၇ ကုဋေ
၁၁.၈၇ ကုဋေ
၁၈.၁၂ ကုဋေ
၁၈.၁၂ ကုဋေ
Operating expense
၃၈.၃၀ ကုဋေ
၃၈.၃၀ ကုဋေ
၄၈.၅၇ ကုဋေ
၄၈.၅၇ ကုဋေ
Total operating expenses
၃၉.၃၈ ကုဋေ
၃၉.၃၈ ကုဋေ
၄၉.၉၃ ကုဋေ
၄၉.၉၃ ကုဋေ
Operating income
-၂၇.၇၀ ကုဋေ
-၂၇.၇၀ ကုဋေ
-၃၂.၉၁ ကုဋေ
-၃၂.၉၁ ကုဋေ
Other non operating income
-၁.၇၅ ကုဋေ
-၁.၇၅ ကုဋေ
-၂.၉၉ သန်း
-၂.၉၉ သန်း
EBT including unusual items
-၂၉.၂၇ ကုဋေ
-၂၉.၂၇ ကုဋေ
-၃၂.၅၄ ကုဋေ
-၃၂.၅၄ ကုဋေ
EBT excluding unusual items
-၂၉.၂၇ ကုဋေ
-၂၉.၂၇ ကုဋေ
-၃၂.၄၈ ကုဋေ
-၃၂.၄၈ ကုဋေ
Income tax expense
၂.၇၆ သန်း
၂.၇၆ သန်း
၇.၁၄ သိန်း
၇.၁၄ သိန်း
Effective tax rate
-၀.၉၄%
-၀.၉၄%
-၀.၂၂%
-၀.၂၂%
Other operating expenses
-
-
-
-
Net income
-၂၉.၅၄ ကုဋေ
-၂၉.၅၄ ကုဋေ
-၃၂.၆၀ ကုဋေ
-၃၂.၆၀ ကုဋေ
Net profit margin
-၂၅၂.၇၉%
-၂၅၂.၇၉%
-၁၉၁.၅၃%
-၁၉၁.၅၃%
Earnings per share
-
-
-
-
Interest and investment income
၁.၅၇ ကုဋေ
၁.၅၇ ကုဋေ
၂.၅၄ ကုဋေ
၂.၅၄ ကုဋေ
Interest expense
-၁.၃၉ ကုဋေ
-၁.၃၉ ကုဋေ
-၁.၃၁ ကုဋေ
-၁.၃၁ ကုဋေ
Net interest expenses
၁.၈၁ သန်း
၁.၈၁ သန်း
၁.၂၂ ကုဋေ
၁.၂၂ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
-၂၅.၇၉ ကုဋေ
-၂၅.၇၉ ကုဋေ
-၃၁.၁၀ ကုဋေ
-၃၁.၁၀ ကုဋေ
Gain or loss from assets sale
-
-
-၃.၃၄ သိန်း
-၃.၃၄ သိန်း
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more